Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pediatric Electrolyte Injection is an intravenous electrolyte solution developed by Shengdi Pharmaceutical (a subsidiary of Jiangsu Hengrui Pharmaceuticals) for pediatric fluid and energy replenishment. It is designed to provide essential electrolytes, including sodium, potassium, calcium, magnesium, and chloride, along with energy substrates such as glucose. The formulation is specifically tailored to the physiological needs of children to maintain or restore fluid and electrolyte balance in patients who are unable to take adequate oral fluids or who have lost significant fluids due to illness or surgery. By providing these essential components, the injection helps prevent electrolyte imbalances and provides metabolic support during recovery.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pediatric electrolyte injection.